These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 34508054)

  • 1. Chasing the Offending Medication: When Antidepressants Lead to Hypoglycemia.
    Singh N; Khetan A; Gupta R
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):698-699. PubMed ID: 34508054
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoglycemia associated with the use of fluoxetine.
    Deeg MA; Lipkin EW
    West J Med; 1996 Mar; 164(3):262-3. PubMed ID: 8775944
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine-induced mania in an Asian patient.
    Pae CU; Lee CU; Lee SJ; Lee C; Paik IH
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):448-9. PubMed ID: 15298662
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine associated with thrombocytopenia and treatment with reboxetine: 3 cases.
    Yucel A; Yucel N; Ozcan H; Gulec M; Aydin A
    J Clin Psychopharmacol; 2015 Jun; 35(3):354-5. PubMed ID: 25822478
    [No Abstract]   [Full Text] [Related]  

  • 5. Ecchymoses as an adverse effect of fluoxetine treatment.
    Fountoulakis KN; Samolis S; Iacovides A; St Kaprinis G
    Psychiatry Res; 2007 Jul; 152(1):91-2. PubMed ID: 17445912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bupropion on sexual dysfunction induced by fluoxetine: a case report of hypersexuality.
    Chollet CA; Andreatini R
    J Clin Psychiatry; 2003 Oct; 64(10):1268-9. PubMed ID: 14658981
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient psychosis with psychogenic polydipsia in schizotypal patient taking fluoxetine.
    Gutkovich Z; Rosenthal RN; Bogdonoff L
    Psychosomatics; 1998; 39(3):295-6. PubMed ID: 9664779
    [No Abstract]   [Full Text] [Related]  

  • 8. A Case of Fluoxetine-Induced Lower Extremity Ecchymosis.
    Çetin B; Ergelen M
    Prim Care Companion CNS Disord; 2017 Jun; 19(3):. PubMed ID: 28636812
    [No Abstract]   [Full Text] [Related]  

  • 9. Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
    Iovieno N; van Nieuwenhuizen A; Clain A; Baer L; Nierenberg AA
    Depress Anxiety; 2011 Feb; 28(2):137-44. PubMed ID: 21284066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.
    Beasley CM; Koke SC; Nilsson ME; Gonzales JS
    Clin Ther; 2000 Nov; 22(11):1319-30. PubMed ID: 11117656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
    Papakostas GI; Petersen T; Denninger JW; Montoya HD; Nierenberg AA; Alpert JE; Fava M
    Ann Clin Psychiatry; 2003; 15(3-4):187-92. PubMed ID: 14971864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder.
    Gudayol-Ferré E; Herrera-Guzmán I; Camarena B; Cortés-Penagos C; Herrera-Abarca JE; Martínez-Medina P; Cruz D; Hernández S; Genis A; Carrillo-Guerrero MY; Avilés Reyes R; Guàrdia-Olmos J
    J Affect Disord; 2010 Dec; 127(1-3):343-51. PubMed ID: 20584552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants and side-effects.
    Sher L
    QJM; 2001 Oct; 94(10):567. PubMed ID: 11588217
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
    Abolfazli R; Hosseini M; Ghanizadeh A; Ghaleiha A; Tabrizi M; Raznahan M; Golalizadeh M; Akhondzadeh S
    Depress Anxiety; 2011 Apr; 28(4):297-302. PubMed ID: 21456039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo.
    Tauscher-Wisniewski S; Nilsson M; Caldwell C; Plewes J; Allen AJ
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):713-8. PubMed ID: 17979590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperthyroidism secondary to antidepressive treatment with fluoxetine].
    Martínez Ortiz JJ
    An Med Interna; 1999 Nov; 16(11):583-4. PubMed ID: 10638001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.